AsteriasBiotherapeutics, Inc. (NYSE: AST) is a biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry-leading platforms are based on its pluripotent stem cell and allogeneic dendritic cell technologies. Asterias is currently focused on the development of therapies based on pluripotent stem cells to treat conditions in several medical areas where there is high unmet medical need and inadequate available therapies. For more information, visit the company’s website at www.asteriasbiotherapeutics.com.